NASDAQ: SLXNSilexion Therapeutics Corp Stock Ownership - Who owns Silexion Therapeutics?
Insider buying vs selling
Have Silexion Therapeutics Corp insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when SLXN insiders and whales buy or sell their stock.
SLXN Shareholders
What type of owners hold Silexion Therapeutics Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Moringa Sponsor LP | 392.95% | 2,875,000 | $11.70M | Insider |
| Ilan Levin | 392.95% | 2,875,000 | $11.70M | Insider |
| Wildcat Capital Management LLC | 15.50% | 113,428 | $461.65k | Institution |
| Ubs Group Ag | 14.93% | 109,257 | $444.68k | Institution |
| Meyer Handelman Co | 4.51% | 32,967 | $134.18k | Institution |
| Moloney Securities Asset Management LLC | 2.73% | 20,000 | $81.40k | Institution |
| Sbi Securities Co Ltd | 2.24% | 16,414 | $66.80k | Institution |
| Virtu Financial LLC | 1.95% | 14,264 | $58.05k | Institution |
| Stonex Group Inc | 1.54% | 11,241 | $45.75k | Institution |
| Bank Of America Corp | 0.07% | 500 | $2.04k | Institution |
SLXN vs Biotech Stocks
Silexion Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.